Covid-19 Vaccine Roll-out Debate
Full Debate: Read Full DebateDan Poulter
Main Page: Dan Poulter (Labour - Central Suffolk and North Ipswich)Department Debates - View all Dan Poulter's debates with the Department of Health and Social Care
(4 years ago)
Commons ChamberUrgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
The Oxford-AstraZeneca vaccine, should it be approved, does have easier logistical and distributional qualities—it does not have to be stored at minus 70°—so that helps. Of course, the JCVI will consider the clinical properties of any vaccine that comes forward when deciding who it can be distributed to, so that is taken into account. Finally, the hon. Gentleman is right to say that this has been an international as well as a UK success. I had a text exchange with my German opposite number this morning to thank, through him, the German scientists who have done so much to make this possible.
I draw the House’s attention to my declaration in the Register of Members’ Financial Interests, as a practising NHS psychiatrist who has been working on the frontline throughout this pandemic. The Secretary of State will be aware that mental health patients are often an afterthought of policymakers, although I am sure that is not the case for him, and that many of them have multiple medical comorbidities, which make them more vulnerable to covid-19. Will he reassure me that patients in mental health services, particularly in-patients, and NHS staff who work in in-patient mental health services will be prioritised for this vaccine and will not be an afterthought?
Absolutely. NHS staff are in the second priority cohort set out by the JCVI, and that includes all patient-facing staff in the NHS and social care. Patients who are clinically vulnerable to covid absolutely have their rightful place in the prioritisation, according to clinical need.